ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 136 filers reported holding ANAPTYSBIO INC in Q3 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,592,000 | +253.2% | 200,000 | +300.0% | 0.01% | +100.0% |
| Q2 2023 | $1,017,000 | +139.9% | 50,000 | +66.7% | 0.01% | -36.4% |
| Q1 2020 | $424,000 | -47.8% | 30,000 | -40.0% | 0.01% | -38.9% |
| Q4 2019 | $813,000 | -76.9% | 50,000 | -50.3% | 0.02% | -81.4% |
| Q3 2019 | $3,523,000 | -24.3% | 100,700 | +22.1% | 0.10% | -9.3% |
| Q2 2019 | $4,655,000 | +6.2% | 82,500 | +37.5% | 0.11% | +87.7% |
| Q1 2019 | $4,383,000 | +129.0% | 60,000 | +100.0% | 0.06% | +119.2% |
| Q4 2018 | $1,914,000 | -42.7% | 30,000 | -36.2% | 0.03% | -44.7% |
| Q2 2018 | $3,342,000 | – | 47,037 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $371,500,000 | 60.25% |
| Cormorant Asset Management, LP | 1,251,485 | $126,050,000 | 13.20% |
| BVF INC/IL | 594,397 | $59,868,000 | 7.22% |
| VHCP Management II, LLC | 282,550 | $28,458,000 | 6.82% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 812,484 | $81,833,000 | 3.22% |
| Iguana Healthcare Management, LLC | 40,000 | $4,029,000 | 2.62% |
| Perceptive Advisors | 756,387 | $76,183,000 | 2.52% |
| Cormorant Asset Management, LP | 135,000 | $13,597,000 | 1.42% |
| EAM Global Investors LLC | 21,734 | $2,189,000 | 1.12% |
| PFM Health Sciences, LP | 425,896 | $42,896,000 | 1.02% |